Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

97.19
-1.1800-1.20%
Post-market: 97.190.00000.00%19:44 EDT
Volume:874.17K
Turnover:85.59M
Market Cap:9.43B
PE:41.57
High:100.00
Open:99.00
Low:97.06
Close:98.37
Loading ...

Sarepta Therapeutics Initiated at Sector Perform by Scotiabank

Dow Jones
·
08 Mar

SLDB Stock Rallies 60% in a Month: Here's What You Should Know

Zacks
·
07 Mar

Sarepta initiated with a Sector Perform at Scotiabank

TIPRANKS
·
07 Mar

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
07 Mar

Statutory Earnings May Not Be The Best Way To Understand Sarepta Therapeutics' (NASDAQ:SRPT) True Position

Simply Wall St.
·
07 Mar

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

StockStory
·
04 Mar

Stock Track | Sarepta Therapeutics Plummets 6.14% on Mixed Shelf Offering Plans

Stock Track
·
04 Mar

BRIEF-Sarepta Therapeutics Inc Files For Mixed Shelf Size Not Disclosed

Reuters
·
04 Mar

Sarepta Therapeutics Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
04 Mar

Stock Track | Sarepta Therapeutics Soars 5% After Announcing Scholarship Program and Upbeat Earnings

Stock Track
·
28 Feb

Sarepta Therapeutics Announces Call for Applications for the 8TH Annual Route 79, the Duchenne Scholarship Program

THOMSON REUTERS
·
28 Feb

Sarepta Therapeutics Announces Call for Applications for the 8th Annual Route 79, The Duchenne Scholarship Program

Business Wire
·
28 Feb

Sarepta Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
28 Feb

Evercore ISI Keeps Their Buy Rating on Sarepta Therapeutics (SRPT)

TIPRANKS
·
28 Feb

Sarepta Therapeutics’ Earnings Call Highlights Record Growth

TIPRANKS
·
28 Feb

Sarepta price target lowered to $210 from $217 at BofA

TIPRANKS
·
27 Feb